Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bluebird Bio
Pharma
Bluebird bio sticks with Carlyle and SK Capital deal
After striking its deal with Carlyle and SK Capital, bluebird said it received a "non-binding written proposal" from Ayrmid that never materialized.
Eric Sagonowsky
Apr 16, 2025 9:30am
Bluebird bio receives rival M&A bid worth 50% higher
Mar 28, 2025 7:14pm
Once valued at $10B, struggling bluebird bio sold for $29M
Feb 21, 2025 10:56am
CDMO Resilience plots job cuts at former bluebird bio facility
Jan 8, 2025 2:47pm
FDA considers 'regulatory action' for bluebird's Skysona
Dec 2, 2024 11:22am
Bluebird bio lays off 25% of workforce
Sep 24, 2024 10:19am
